The purpose of this study was to assess the progression of cardiac involvement in adult
patients with Fabry Disease (FD), in the unique Danish Fabry cohort and comparing those FD
patients receiving primary therapy vs. those that did not.
The hypothesis is, that we will not be able to see a significant positive difference in
cardiac involvement in those FD patient who received FD specific therapy vs. those that did